Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo - Powell, D J, Jr; Felipe-Silva, A; Merino, M J (J Immunol, 2007)
, et al.